Fas ligand

Related Overviews


'Fas ligand' can also refer to...

Fas ligand

Fas ligand

The Fas ligand/Fas system in renal injury

Contribution of Fas ligand to cardiac allograft rejection

Expression of Fas and Fas ligand mRNA in rat and human preimplantation embryos

Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells

Fas ligand, Fas antigen and Bcl-2 expression in human endometrium during the menstrual cycle

The Fas/Fas Ligand Apoptotic Pathway Is Involved in Abrin-Induced Apoptosis

Are Fas Ligand Polymorphisms Associated With Occult HBV Infection?

Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand

Involvement of IL-17 in Fas ligand-induced inflammation

Turnover of Neutrophils Mediated by Fas Ligand Drives Leishmania major Infection

Double role of Fas ligand in the apoptosis of intervertebral disc cells in vitro

Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand

First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis

Regulation of Fas ligand expression by vascular endothelial growth factor in endometrial stromal cells in vitro

Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion.

Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action

Fas-Fas Ligand (CD95-CD95L) and Cytotoxic T Lymphocyte Antigen-4 Engagement Mediate T Cell Unresponsiveness in Patients with Paracoccidioidomycosis


More Like This

Show all results sharing this subject:

  • Chemistry


Show Summary Details

Quick Reference

A homotrimeric protein on the cytotoxic T cell surface which binds to transmembrane receptor proteins on the target cell called Fas. The binding alters the the Fas proteins so that their clustered cytosolic tails recruit procaspase‐8, which leads to apoptosis.


Subjects: Chemistry.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.